Solid-State NMR Analysis of the PGLa Peptide Orientation in DMPC Bilayers: Structural Fidelity of 2H-Labels versus High Sensitivity of 19F-NMR  by Strandberg, Erik et al.
Solid-State NMR Analysis of the PGLa Peptide Orientation in
DMPC Bilayers: Structural Fidelity of 2H-Labels versus High
Sensitivity of 19F-NMR
Erik Strandberg,* Parvesh Wadhwani,* Pierre Tremouilhac,* Ulrich H. N. Du¨rr,y and Anne S. Ulrich*y
*Institute for Biological Interfaces, Forschungszentrum Karlsruhe, 76344 Eggenstein-Leopoldshafen, Germany; and
yInstitute of Organic Chemistry, University of Karlsruhe, 76131 Karlsruhe, Germany
ABSTRACT The structure and alignment of the amphipathic a-helical antimicrobial peptide PGLa in a lipid membrane is
determined with high accuracy by solid-state 2H-NMR. Orientational constraints are derived from a series of eight alanine-3,3,3-
d3-labeled peptides, in which either a native alanine is nonperturbingly labeled (43 ), or a glycine (23 ) or isoleucine (23 ) is
selectively replaced. The concentration dependent realignment of the a-helix from the surface-bound ‘‘S-state’’ to a tilted
‘‘T-state’’ by 30 is precisely calculated using the quadrupole splittings of the four nonperturbing labels as constraints. The
remaining, potentially perturbing alanine-3,3,3-d3 labels show only minor deviations from the unperturbed peptide structure and
help to single out the unique solution. Comparison with previous 19F-NMR constraints from 4-CF3-phenylglycine labels shows
that the structure and orientation of the PGLa peptide is not much disturbed even by these bulky nonnatural side chains, which
contain CF3 groups that offer a 20-fold better NMR sensitivity than CD3 groups.
INTRODUCTION
Solid-state NMR is a powerful tool to resolve the three-
dimensional structures of membrane-active peptides embed-
ded in lipid bilayers (1,2). For simple a-helical or b-stranded
peptides, it is straightforward to collect a number of orienta-
tional constraints, from which the molecular conformation can
be veriﬁed and its membrane alignment and dynamic behavior
deduced (3). For each constraint, a selective isotope label has
to be placed into a suitable position on the peptide, where it
reﬂects its overall fold. Nonperturbing 15N- and 13C-isotopes
are conveniently substituted in the backbone, and 2H-labels
can be utilized in the side chains. For the latter, alanine-3,3,3-
d3 (Ala-d3) is most suitable, since the methyl group is attached
directly to the backbone and reﬂects the orientation of the
entire peptide segment (4,5).
A drawback of these conventional isotopes is their low
sensitivity, which calls for large amounts of material, high
peptide concentration in the sample, and comparatively long
measurement times. Fluorine, on the other hand, is a nucleus
with much higher NMR sensitivity, though this nonnatural
label might disturb the system (3,6). Several peptide struc-
tures have been resolved by 19F-NMR, whereby the most
successful approach is based on 4-CF3-phenylglycine (CF3-
Phg) side chains, which are conceptually analogous to
Ala-d3. (7–11). Here, we have carried out a comprehensive
2H-
NMR structure analysis of a membrane-bound antimicrobial
peptide labeled with Ala-d3 to compare these results with an
analogous set of 19F-NMR data based on an earlier CF3-Phg
study. The respective advantages and disadvantages of the
two approaches will be discussed in terms of structural
ﬁdelity and experimental sensitivity.
Membrane-active antimicrobial peptides with typically
10–50 amino acids are found in many organisms as part of
the immune system to defend the host against invading
bacteria and other microorganisms (12–15). These peptides
kill bacteria presumably by disrupting their cell membranes.
They tend to have an overall amphiphilic structure, which
explains their high afﬁnity for lipid bilayers. To understand
their detailed mode of action, it is important to examine their
structure in association with membranes at a molecular level,
for which solid-state NMR is particularly well suited (1). The
peptide PGLa (GMASKAGAIAGKIAKVALKAL-NH2) is
found in the skin of Xenopus laevis (16–18) and belongs to
the magainin family (19). The amino acid sequence suggests
an amphiphilic a-helical structure with charged lysine side
chains on one side and hydrophobic residues on the oppo-
site face (see Fig. 1). This conformation was conﬁrmed by
1H-NMR in detergent micelles, and by solid-state 15N-NMR
in the membrane-bound state (10,20). Using 15N-labels in
the peptide backbone, a ﬂat surface alignment was demon-
strated for the helix, although with a large margin of error
and no information on its azimuthal rotation.
More recently, our 19F-NMR analysis of CF3-Phg sub-
stituted peptides yielded not only the tilt angle and azimuthal
rotation of PGLa, but also revealed a concentration-dependent
realignment in the membrane (9–11). It appears that increasing
peptide concentration triggers a conversion from a monomeric
surface-bound ‘‘S-state’’, with the helix axis aligned ;90
with regard to the bilayer normal, to a tilted ‘‘T-state’’ with a
tilt angle of;120, whereby the amidated C-terminus of the
a-helix becomes obliquely immersed into the bilayer. This
novel T-state was rationalized in terms of oligomerization,
given that PGLa and other related peptides are prone to homo-
or heterodimerization (21–23). According to the commonly
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accepted picture of antimicrobial peptides, a reorientation may
have been expected to lead to a fully upright transmembrane
alignment in the so-called immersed ‘‘I-state’’ (with a cor-
responding angle of;0), as predicted by the Shai-Matzusaki-
Huang model of antimicrobial function (24–26). Instead, the
observation of an oblique tilt angle was interpreted as indirect
evidence that PGLa might rather dimerize in the membrane
under the conditions studied. In this study, we wanted to
conﬁrm the unexpected realignment seen by 19F-NMR, and to
determine the respective tilt angles with higher accuracy.
Here, a comprehensive 2H-NMR structure analysis is
carried out on PGLa, using a series of peptides labeled with
Ala-d3 in place of Ala, Gly, or Ile (Table 1). Substitution of a
native Ala by Ala-d3 will obviously cause no structural
perturbation at all. This 2H-NMR approach, called GALA
(geometric analysis of labeled alanines), has previously been
used on transmembrane peptides (4,5,27–29). A similar
approach based on dipolar waves was also presented by
Opella et al. (30). To our knowledge, this is the ﬁrst time that
quadrupolar waves are applied to a peripherally bound
membrane peptide with a potentially nonideal a-helix. Much
attention is therefore paid to the error analysis, not only in
terms of the global peptide structure but also with regard to
the local deviation of any individual labeled position. The
resulting 2H-NMR model structure is then compared to our
previous results from 19F-NMR (10,11) and 15N-NMR (11).
The accuracy and reliability of the NMR data using the dif-
ferent labeling strategies will thus be critically assessed.
MATERIALS AND METHODS
Materials
Dimyristoylphosphatidylcholine (DMPC) was purchased from Alexis Bio-
chemicals (Lausen, Switzerland) or Avanti Polar Lipids (Alabaster, AL), and
deuterium-depleted water was from Acros (Schwerte, Germany) and Sigma-
Aldrich (Taufkirchen, Germany). Ala-d3 was purchased from Cambridge
Isotope Laboratories (Andover, MA) and Fmoc-protected (31). PGLa was
labeled at eight different positions, one at a time, replacing alanine, glycine, or
isoleucine with Ala-d3 (Table 1). All peptides were synthesized on an Applied
Biosystems (Foster City, CA) 433A instrument, using standard solid phase
Fmoc-protocols (32). The crude material was puriﬁed by high-performance
liquid chromatography on a C18 column using an acetonitrile/water gradient.
The identity of the products was conﬁrmed by MALDI-TOF mass spectrom-
etry. After puriﬁcation, all peptides were ;95% pure.
Sample preparation
Oriented samples
Appropriate amounts of peptides and lipids were codissolved in ;400 ml
methanol/CHCl3 1:1 (v/v) and spread onto 25 thin glass plates of dimensions
18 mm 3 7.5 mm 3 0.08 mm (Marienfeld Laboratory Glassware, Lauda-
Ko¨nigshofen, Germany). The plates were dried in air for 1 h, followed by
drying under vacuum overnight. They were stacked and placed into a
hydration chamber with 96% relative humidity at 48C for 24–48 h, before
wrapping the stack in paraﬁlm and plastic foil for the NMR measurements.
Nonoriented samples
Appropriate amounts of peptides and lipids were codissolved in ;200 ml
methanol/CHCl3 1:1 (v/v). In samples with a peptide/lipid ratio of P/L ¼
1:200, typically 2 mg peptide plus 140 mg lipid were used, and in 1:50
samples ;4 mg peptide plus 70 mg lipid. The solution was dried under a
stream of N2, followed by vacuum drying for overnight. Deuterium-depleted
water was added to the dry lipid-peptide mixture to reach 50% by total
FIGURE 1 Helical wheel representation of the amphiphilic PGLa peptide,
displayed here with the correct azimuthal rotation angle r ¼ 115 as it was
found to reside in the membrane (dark shaded box). The positions labeled
with Ala-d3 are marked with circles, and the charged lysines with ‘‘1’’.
TABLE 1 Amino acid sequences of the peptides used and quadrupole splittings (in kHz) measured in PGLa-Ala-d3/DMPC samples
Peptide Labeled position Sequence P/L ¼ 1:200* P/L¼ 1:200y P/L ¼ 1:50z
PGLaWT None GMASKAGAIAGKIAKVALKAL-NH2
PGLa6 Ala-6 GMASK-Ala-d3-GAIAGKIAKVALKAL-NH2 7.8 15.6 18.2
PGLa7 Gly-7 GMASKA-Ala-d3-AIAGKIAKVALKAL-NH2 4.8 9.6 2.5
PGLa8 Ala-8 GMASKAG-Ala-d3-IAGKIAKVALKAL-NH2 8.6 17.2 42.0
PGLa9 Ile-9 GMASKAGA-Ala-d3-AGKIAKVALKAL-NH2 2.6 5.2 30.0
PGLa10 Ala-10 GMASKAGAI-Ala-d3-GKIAKVALKAL-NH2 7.5 15.0 30.3
PGLa11 Gly-11 GMASKAGAIA-Ala-d3-KIAKVALKAL-NH2 18.5 37.0 52.1
PGLa13 Ile-13 GMASKAGAIAGK-Ala-d3-AKVALKAL-NH2 13.2 26.4 20.1
PGLa14 Ala-14 GMASKAGAIAGKI-Ala-d3-KVALKAL-NH2 13.3 26.6 21.5
*90 edge of Pake powder pattern.
y0 edge of Pake powder pattern.
zOriented samples aligned with the bilayer normal along B0.
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weight. The sample was thoroughly mixed by vortexing and freeze-thawed
several times. It was then transferred into a small polyethylene bag that was
heat-sealed and placed into a second sealed plastic bag to avoid dehydration
during NMR experiments. When not used for NMR experiments, the
samples were stored at 20C.
NMR spectroscopy
All measurements were carried out on a Bruker Avance 500 MHz NMR
spectrometer (Bruker BioSpin, Rheinstetten, Germany) at 308 K. 31P-NMR
was performed at a frequency of 202.5 MHz using a Hahn echo sequence
with phase cycling (33) with a 7 ms 90 pulse, 30ms echo time, 2 s relaxation
delay time, 100 kHz spectral width, 4096 data points, and proton decoupling
using tppm20 (34). Typically, 128 scans were collected, and spectra were
processed by left-shifting the free induction decay to start at the echo
maximum, zero ﬁlling to 16,384 data points, and a 100 Hz exponential
multiplication before Fourier transformation.
2H-NMR experiments were performed at 76.77 MHz using a quadrupole
echo sequence (35) with a 4.5 ms 90 pulse, an echo delay of 30 ms, an 80 ms
relaxation delay time, 250 kHz spectral width, and 2048 data points.
Between 300,000 and 1,000,000 scans were collected. Acquisition was
started before the echo, and the time domain data was left-shifted to get the
free induction decay starting at the echo maximum before further processing
by zero ﬁlling to 16,384 data points and a 200 Hz exponential multiplication
followed by Fourier transformation.
Structure calculations
The measured NMR parameters (quadrupole splittings of Ala-d3, and
19F-19F dipole couplings of CF3-Phg) were compared to a model of the
peptide as an ideal a-helix. To determine the helix tilt angle t, the azimuthal
rotation r around the helix axis, and the order parameter Smol, a least-squares
ﬁt was performed to ﬁnd the globally smallest root mean-square deviation
(rmsd) between the experimental and calculated NMR parameters
(5,8,10,36). Further analysis of this rmsd minimum was performed using
the GALA approach described earlier (4,5), which allows a graphical
visualization of the error range for each labeled position.
To describe the peptide alignment in a membrane, the tilt angle t deﬁnes
the angle between the peptide helix axis and the bilayer normal. To be
consistent with our earlier PGLa analysis (10,11), but in contrast to earlier
deﬁnitions in Strandberg et al. (2004), the azimuthal angle r is deﬁned as a
right-handed rotation around the helix axis, with the axis directed from the
N- to C-terminus. Here, r ¼ 0 is deﬁned as the orientation when the vector
projecting radially from the helix axis to the Ca atom of Lys-12 is aligned
parallel to the membrane plane, as illustrated in Fig. 1. The angles describing
the orientation of the Ca-Cb bond were for all residues taken as b ¼ 121.1
and a ¼ 53.2, as deduced from an a-helical polyalanine model constructed
in SYBYL using f¼58 and c¼ –47 (10). Here, b is the angle between
the bond vector and the peptide axis, and a is the angle between the bond
vector and the vector from the peptide axis to the Ca atom. The quadrupole
coupling constant used was e2qQ/h ¼ 167 kHz (37). Since signs of the 2H
quadrupole splittings were not available, the absolute values were used in the
analysis, whereas signs of the 19F dipole couplings were accessible from the
anisotropic chemical shift seen in the same one-pulse spectra (10).
The order parameter Smol describes local internal oscillations and global
wobbling motions of the molecule. Its effect in our calculations is to reduce
all splittings by a constant factor, assuming a uniaxial ordering tensor.
RESULTS
Choice of oriented or nonoriented samples
Orientational constraints are most readily extracted from
macroscopically oriented membrane samples. Provided that a
well-oriented peptide undergoes long-axial rotation about the
membrane normal, these parameters are also available from
nonoriented multilamellar lipid dispersions (5,8,38). Samples
for 2H-NMR with PGLa embedded in DMPC were prepared
both ways. The 31P-NMR line shapes of all nonoriented
samples showed a single lamellar phase with no indication of
any isotropic or nonlamellar signals. For oriented samples, 31P
was used to determine the degree of orientation of the lipids.
Typically, the well-oriented peak at low ﬁeld contributed 70–
80% to the integrated intensity, with the rest originating from
nonoriented parts of the sample.
The 2H-NMR spectra of oriented samples showed
orientation-dependent quadrupole splittings. When the glass
plates were oriented with their normal parallel to the mag-
netic ﬁeld, the splittings were twice as large as for an ori-
entation of the sample normal perpendicular to the ﬁeld
direction. This was the case at both peptide/lipid ratios (P/L)
of 1:200 and 1:50, indicating that the peptides are rotating
fast around the bilayer normal at 35C in the liquid crys-
talline state of DMPC, as previously seen with 19F-NMR
(10,11). Nonoriented samples showed characteristic Pake
patterns with splittings close to the ones in (perpendicularly)
oriented samples. These results show that the peptides are
well oriented and rotating fast, hence the same information
can be obtained from liquid crystalline nonoriented samples
as from oriented samples.
In previous 19F-NMR studies of PGLa in lipid systems, we
had used only oriented samples. However, as they are harder to
prepare with the large amount of material required for the less
sensitive 2H-NMR measurements especially at low peptide
concentration, we decided to use nonoriented dispersion sam-
ples at P/L ¼ 1:200 and oriented samples at P/L ¼ 1:50.
2H-NMR results
The 2H-NMR spectra of PGLa labeled at eight different
positions with Ala-d3 are shown in Fig. 2, for two different
concentrations of peptides in DMPC. A P/L of 1:200 will be
denoted as a ‘‘low’’ peptide concentration, whereas P/L ¼
1:50 is called ‘‘high’’ concentration. At low peptide
concentration, the Pake pattern from the peptide is seen in
all spectra, besides a sharp isotropic component due to traces
of HDO in the hydrated samples. In some cases, the peptide
splitting is too small to be resolved and contributes to the
isotropic peak. There is also a low intensity component with
a splitting of ;26 kHz, which is attributed to natural
abundance deuterons in the lipids, as demonstrated by 2H-
NMR of pure lipid samples (data not shown). At high peptide
concentration, a single dominant splitting is seen from the
peptides in the oriented samples. The central component is
smaller, as there is no excess water in these samples. In
nonoriented samples, the main peak originates from parts of
the membrane with the bilayer normal perpendicular to the
magnetic ﬁeld, whereas oriented samples are measured with
their normal parallel to the magnetic ﬁeld. Therefore, for
comparison, the splittings for nonoriented samples should be
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doubled. The peptide quadrupole splittings of all spectra are
listed in Table 1. Since the splittings for any one label are
different at low and high peptide concentration, this clearly
indicates a concentration-dependent realignment of PGLa in
the lipid bilayer.
It is generally possible to describe the alignment and
dynamics of a peptide in the membrane by three parameters,
namely the tilt angle t of the helix axis with respect to the
bilayer normal, the azimuthal rotation angle r around the
helix axis, and the molecular order parameter Smol (1,3–5,
7,8,10,11,36,39). Given that the effective (time-averaged)
quadrupole tensor is collinear with the C-CD3 axis in the
molecular frame of PGLa, at least three orientational con-
straints are required to determine the three unknown para-
meters t, r, and Smol. In practice, more than three are needed,
since the sign of a quadrupole splitting is not accessible,
which leads to multiple solutions (40–43). It was found in a
previous study that four labeled positions gave reliable
results (5).To perform the structure analysis, the conforma-
tion of the peptide in the bilayer has to be known. PGLa was
shown by circular dichroism to have a random structure in
solution and to form an a-helix in the presence of lipid
bilayers (10,44,45). 1H-NMR conﬁrmed an a-helix between
residues 6 and 21 when PGLa was associated with DPC
micelles (20). We therefore assumed an ideal (polyalanine)
a-helix as a model structure for PGLa, to ﬁt the quadrupole
splittings of the different labeled positions in the peptide. In a
grid search for the best-ﬁt structure, the theoretical quadru-
pole splittings are calculated for different values of t, r, and
Smol. The parameters t and r are changed in steps of 0.1,
and Smol in steps of 0.01 to ﬁnd the lowest rmsd with regard
to the experimental data.
Helix alignment at low peptide concentration
Native alanine positions
The substitution of 1H by 2H does not perturb the chemical
properties of a molecule. Thus, a substitution of Ala by Ala-
d3 will not affect the molecular behavior of wild-type PGLa.
However, when any other amino acid (in this case Gly or Ile)
is replaced by Ala-d3, such mutation might change the pro-
perties of the peptide. Therefore, the 2H-NMR data analy-
sis was ﬁrst performed by taking into account only the
orientational constraints from the four native Ala positions in
the sequence, i.e., using the quadrupole splittings from Ala-
6, Ala-8, Ala-10, and Ala-14. For a P/L ¼ 1:200, this
analysis produces a peptide structure with a helix tilt angle
t ¼ 98, a rotation angle r ¼ 115, and an order parameter
Smol ¼ 0.66 (Table 2). This result corresponds to an align-
ment of the peptide helix almost ﬂat on the membrane
surface in the so-called S-state (24,26), with the charged
lysine side chains pointing up toward the water (Fig. 1). The
numerical value of the tilt angle being higher than 90means
that the amidated C-terminus is inserted slightly deeper into
the membrane than the charged N-terminus. This structure is
in good agreement with our previous 19F-NMR analysis,
where a tilt angle t  89, a rotation r  115, and an order
parameter Smol  0.6 had been obtained (10). Notably, the
signs of the four quadrupole splittings used in our 2H-NMR
analysis are unknown and may produce additional solutions
as artifacts, whereas the signs of the four dipolar splittings of
CF3-Phg had been directly accessible via the
19F chemical
shift anisotropy (10). Nevertheless, the current set of four
2H-NMR constraints gives an rmsd of 1.3 kHz, which is
convincingly small for this solution to be unique and reliable.
The quality of the ﬁts can be assessed using two-
dimensional error plots as well as quadrupolar waves. Fig.
3 A shows the error plot for the ﬁt using the four native Ala-
d3 labels. Here, the rmsd error (in kHz) is illustrated by a
grayscale for all combinations of t and r. If we had also
wanted to display the dependence on the order parameter,
this would require a three-dimensional error plot, hence we
only shown the t/r map obtained for the best-ﬁt order
parameter value Smol ¼ 0.66. There exist several minima
with an rmsd below 2.0 kHz since the signs of the four
quadrupole splittings are not known, but the solution with a
tilt angle near 100 is clearly the best ﬁt. The corresponding
quadrupolar wave is shown in Fig. 3 B and represents the
FIGURE 2 2H-NMR spectra of PGLa labeled with Ala-d3 in eight
different positions (as numbered) and reconstituted in DMPC at P/L¼ 1:200
(left panel), and 1:50 (right panel). The samples with low peptide con-
centrations were prepared as multilamellar lipid dispersions and show Pake
patterns, whereas all samples with high concentration were prepared as mac-
roscopically oriented membranes and show sharp splittings.
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unperturbed peptide structure (t ¼ 98, r ¼ 115, Smol ¼
0.66). Here, the hypothetical quadrupole splittings are cal-
culated for each position around the helical wheel and dis-
played on a curve from 0 to 360. None of the experimental
data points deviate signiﬁcantly from the theoretical wave,
which conﬁrms that the labeled stretch is consistent over its full
length with an unperturbed a-helical conformation.
The experimental error in the quadrupole splittings is
estimated to be no more than 1 kHz, as found by repeated
measurements on a sample or by use of duplicate samples.
All rmsd values below this must be called ‘‘good’’ ﬁts. It
should also be noted that our analysis is based on the as-
sumption of an ideal a-helical structure. Slight deviations are
expected for amphiphilic peptides at the membrane surface;
hence even larger rmsd values may be acceptable. In a pre-
vious study on uniformly hydrophobic transmembrane model
peptides, the ﬁt to an ideal helix had been justiﬁed by the
very small rmsd values of typically,1 kHz found for such a
model (4,5). For PGLa at 1:200, the error in t and r is;63
in both cases, according to the area in the error plot that
covers an rmsd of 1 kHz around the best ﬁt.
Glycine or isoleucine substituted with alanine
When the two Gly/Ala-d3 substitutions were included in the
analysis at P/L ¼ 1:200, the same best-ﬁt values (within the
error of the method) were found as when only nonperturbing
native Ala labels were used (Table 2). Likewise, when two
Ile/Ala-d3 substitutions were included, the same best-ﬁt
values were obtained, although with a slightly higher rmsd
error of 2.2 kHz. When all eight labeled positions were com-
bined, the best-ﬁt values of t, r, and Smol remained the same
as in the entirely unperturbed structure, as seen in Table 2. The
corresponding error plot in Fig. 3 C is now showing one
clearly deﬁned global minimum, and the many shallow min-
ima of Fig. 3 A have disappeared. The additional data from the
potentially perturbing labels thus conﬁrm the unique and well-
deﬁned orientation of PGLa. In the quadrupolar wave plot in
Fig. 3 B, the experimental splittings from the Gly or Ile po-
sitions (open symbols) lie close to the original curve calcu-
lated from the native Ala-d3 labels alone (solid symbols). We
conclude that the structure and orientation of PGLa at 1:200
are not inﬂuenced by the substitution of a small glycine
residue nor a bulky isoleucine side chain by an alanine.
Helix alignment at high peptide concentration
Native alanine positions
At a high peptide concentration of P/L ¼ 1:50, the
orientation parameters derived as the best-ﬁt solution are
given in Table 2. Again, we initially used only the four labels
in native Ala positions to obtain a reliable structure, and the
result is clearly different from that at low peptide con-
centration. The best-ﬁt values are t ¼ 126, r ¼ 110, and
Smol¼ 0.75. This means that the tilt angle is;30 larger than
at the low peptide concentration, whereas the azimuthal
rotation angle and the order parameter do not change much.
In the corresponding error plot of Fig. 4 A, this minimum is
the deepest, with an rmsd of only 0.5 kHz. This error is even
smaller than the intrinsic experimental error. There are also
two other minima corresponding to tilt angles t of;25 and
60, but with considerably larger errors. We are conﬁdent that
t ¼ 126 is the correct solution for P/L¼ 1:50, since a similar
picture was obtained by 19F-NMR from four Phg-CF3 labels
for which the signs of the dipolar splittings were known (11).
Glycine or isoleucine substituted with alanine
We next included the 2H-NMR data from the Ile and Gly
substitutions in the analysis at high peptide concentration, for
comparison with the unperturbed structure. In the quad-
rupolar wave plot of Fig. 4 B, the curve represents the best ﬁt
derived from the splittings of the four native Ala positions
only (solid symbols), whereas the other splittings of the
potentially perturbing labels are displayed with open sym-
bols. The data points from the substituted positions (Gly-7,
Gly-11, Ile-9, and Ile-13) ﬁt almost perfectly to the wave,
and an independent best-ﬁt analysis using all eight positions
gave practically the same values (t ¼ 126, r ¼ 111, and Smol
¼ 0.78). The corresponding error plot in Fig. 4 C now shows a
single well-deﬁned minimum with an rmsd of 1.2 kHz. We
thus conclude that also at high peptide concentration,
TABLE 2 Best-ﬁt orientation parameters for PGLa in DMPC; potentially perturbing substitutions are highlighted
P/L Labels used Tilt angle t () Rotation angle r () Smol rmsd (kHz)
1:200 CD3 at Ala-6, Ala-8, Ala-10, Ala-14 98 115 0.66 1.3
CD3 at Ala-6, Gly-7, Ala-8, Ala-10, Gly-11, Ala-14 98 115 0.69 1.4
CD3 at Ala-6, Ala-8, Ile-9, Ala-10, Ile-13, Ala-14 98 114 0.68 2.2
CD3 at Ala-6, Gly-7, Ala-8, Ile-9, Ala-10, Gly-11,
Ile-13, Ala-14
98 115 0.70 2.0
CF3 at Ile-9, Ala-10, Ile-13, Ala-14 89 116 0.63 0.3
1:50 CD3 at Ala-6, Ala-8, Ala-10, Ala-14 126 110 0.75 0.5
CD3 at Ala-6, Gly-7, Ala-8, Ala-10, Gly-11, Ala-14 127 109 0.74 1.0
CD3 at Ala-6, Ala-8, Ile-9, Ala-10, Ile-13, Ala-14 124 112 0.78 0.9
CD3 at Ala-6, Gly-7, Ala-8, Ile-9, Ala-10, Gly-11,
Ile-13, Ala-14
126 111 0.78 1.2
CF3 at Ile-9, Ala-10, Ile-13, Ala-14 123 95 0.63 0.2
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the substitution of Gly or Ile by Ala does not cause any
signiﬁcant perturbation.
DISCUSSION
In this study, we have used solid-state 2H-NMR on
selectively Ala-d3 labeled PGLa to determine the orientation
of this antimicrobial peptide in a lipid bilayer at different
concentrations. First, we will assess the results in the light of
those obtained previously on transmembrane peptides. Then
we will compare the different PGLa structures at low and
high peptide concentration. We will also include previous
data from analogous 19F- and 15N-NMR studies on PGLa
and examine the local deviations of these combined results.
Finally, the different labeling strategies for solid-state NMR
studies of membrane peptides will be critically discussed with
regard to accuracy on the one hand, and practical aspects
such as NMR sensitivity on the other hand.
Comparison of surface-bound and
transmembrane peptides
In previous 2H-NMR studies of the transmembrane model
peptides WALP19 (GWW(LA)6LWWA) and WALP23
(GWW(LA)8LWWA) labeled with Ala-d3, the helices were
found to span the membrane with a small tilt angle t of up to
8 (4,5). This tilt was found to depend on the hydrophobic
thickness of the membrane, as it assumed a slightly larger
value when the peptide was too long to span the lipid bilayer.
The quality of ﬁt of the NMR data was very good and
deteriorated only when the peptide-lipid hydrophobic mis-
match became signiﬁcant. For WALP23 in DOPC, the rmsd
error from eight labeled positions was below 0.5 kHz,
meaning that the peptide forms a virtually ideal a-helix. For
WALP23 in DMPC, and for WALP19 in DLPC, DMPC and
DOPC, the rmsd was below 1.0 kHz. Only for a considerable
mismatch was there a larger error. In a more recent study,
similar transmembrane peptides KALP23, WLP23, and
KLP23 were examined the same way in the same lipid
bilayers, and their mismatch-dependent tilt between 4 and
12 also showed rmsd values below 1.0 kHz (46). These
reports demonstrate that transmembrane a-helices are close
to ideal, as expected, since breaking or even distorting a hy-
drogen bond in the hydrophobic environment would be ex-
pensive in terms of free energy.
In the case of PGLa, the amphiphilic a-helix is embedded
in the membrane surface. It may be expected to be less
symmetric in such location, since one side of the peptide
faces a polar environment where the CO and NH groups
could form hydrogen bonds with solvent molecules or with
the lipid headgroups. It has been reported that in amphiphilic
helices, the hydrogen bonds are shorter on the hydrophobic
face than on the hydrophilic face (47,48), which would cause
the helix to bend and deviate from the ideal model. In our
study, such conformational effects were not taken into
account, and the two helical turns from Ala-6 to Ala-14 were
ﬁtted to an ideal a-helical model of polyalanine, with torsion
angles f ¼ 58 and c ¼ 47. Given the heterogeneous
primary sequence of PGLa, the Ala residues in different
FIGURE 3 (A) Error plot for PGLa/DMPC at 1:200, using only the
2H-NMR data from the four nonperturbing positions Ala-6, Ala-8, Ala-10, and
Ala-14. (B) Quadrupolar wave plot, with the curve ﬁtted only to the four native
Ala positions (n). The experimental splittings from two Ile positions (s) and
two Gly positions (n) are also shown, with residue numbers given next to the
data points. (C) Error plot calculated from all eight labeled Ala-d3 positions,
showing a unique minimum that conﬁrms the best-ﬁt solution from panel A.
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positions have different neighboring amino acids, which may
further change their local torsion angles to some extent. In
contrast, the WALP peptides are very regular, as all Ala have
Leu neighbors. It is therefore not surprising that the rmsd
values obtained here, on the order of a few kHz, are
signiﬁcantly larger than for the transmembrane helices.
Indeed, in previous 19F-NMR studies of PGLa and other
peptides, we have carried out a systematic structure anal-
ysis based on different a-helical starting models, and it
turned out that the uncertainty of the chosen conformational
model introduced a larger error than the intrinsic experi-
mental data (10,39).
Concentration-dependent realignment of PGLa
At a low concentration of P/L ¼ 1:200, the best-ﬁt structure
based on the four native Ala residues only, shows that PGLa
lies almost ﬂat on the bilayer surface in the so-called S-state
(t ¼ 98). The charged lysine residues point toward the aqueous
layer and the hydrophobic residues are in contact with the
lipid bilayer interior, as illustrated by the azimuthal rotation
of the helical wheel in Fig. 1. At a high concentration of
P/L ¼ 1:50, the helix tilt angle t increases by ;30 to 125,
whereas the azimuthal rotation angle r of 115 remains
almost unchanged, and the order parameter Smol increases
slightly. This tilted state was ﬁrst qualitatively observed by
19F-NMR and called the T-state, and it has now been
unambiguously conﬁrmed by 2H-NMR using unperturbed
PGLa.
Besides labeling the four native Ala positions, Ala-d3 was
also used to substitute Gly-7, Gly-11, Ile-9, or Ile-13 (Table
1). When the orientational constraints from these labels are
included in the structure analysis, their individual quadrupole
splittings ﬁt well to the quadrupolar wave from the four native
Ala labels, both at low and high peptide concentration (Figs.
3 B and 4 B). This ﬁnding suggests that a substitution of
Gly/Ala-d3 or Ile/Ala-d3 does not signiﬁcantly affect the
peptide conformation or its alignment in the membrane. In the
case of monomeric PGLa at low concentration, the helix
orientation appears to be dictated by the overall amphiphilicity
of the peptide; hence a conservative mutation can be readily
accommodated. At high peptide concentration, the picture
may be regarded as more complex, given that the formation of
antiparallel dimers has been invoked to explain the change in
the peptide tilt angle (11). When a dimer is formed, we can
now tell that the alignment and the crossing angle of the
packed molecules are not affected by any of the substitutions
made here. This may mean that either the dimer interface is
rather soft and can accommodate such variations in the size of
the side chain, or, alternatively, our mutations may simply not
have involved the putative dimer interface. Note that Gly-7
and Gly-11 are located on the left side of the helical wheel in
Fig. 1, whereas Ile-9 and Ile-13 are situated on the opposite
side. None of the positions in the Ala-rich quadrant facing
down (Ala-14 to Ala-6) have been targeted yet by any 2H-
NMR mutations. It is interesting to note that a related peptide
K3, which had been designed on the basis of the PGLa
sequence, was recently shown to form homodimers in the
membrane-bound state via its Ala-rich surface (23,49).
FIGURE 4 (A) Error plot for PGLa/DMPC at 1:50, using only the
2H-NMR data from the four nonperturbing positions Ala-6, Ala-8, Ala-10, and
Ala-14. (B) Quadrupolar wave plot, with the curve ﬁtted only to the four native
Ala positions (n). The experimental splittings from two Ile positions (s) and
two Gly positions (n) are also shown, with residue numbers given next to the
data points. (C) Error plot calculated from all eight labeled Ala-d3 positions,
showing a unique minimum that conﬁrms the best-ﬁt solution from panel A.
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Comparison with previous 15N- and
19F-NMR results
In a previous study, PGLa was labeled with 15N in the amide
bond of Gly-11, whose chemical shift was measured in
oriented samples of PGLa/DMPC at P/L ¼ 1:200 and 1:50
(10). 15N is a nondisturbing isotope label, giving conforma-
tionally unperturbed results. A single 15N label is sufﬁcient to
estimate the peptide tilt angle, but gives no information about
the azimuthal rotation. In PGLa, the chemical shift changed
from 40 ppm (referenced to 15NH4NO3) at low peptide
concentration to 68 ppm at high concentration. This signif-
icant change suggested a realignment of the peptide helix from
a tilt angle of t  90 to ;115 (11), which is nicely
compatible with the results from 2H-NMR presented here. The
analysis from a single 15N-label is associated with a broad
error in t (620), since the relevant chemical shift anisotropy
(CSA) interactions are not colinear with the helix axis, and
since the principal axes values may differ slightly from one
amino acid to another. A single 15N label does not reveal the
azimuthal rotation angle r either. A more comprehensive
picture is available from the dipolar couplings of multiple NH
bonds, which can be analyzed in terms of PISA (polarity index
slant angle) wheels or dipolar waves (2,30) analogously to the
quadrupolar waves presented here.
As a highly sensitive alternative to conventional isotopes,
we have previously introduced 19F-labeling for solid-state
NMR structure analysis of membrane-active peptides (3,7–
9,36,39,50). The structure and alignment of PGLa in DMPC
bilayers was studied using four peptide analogs labeled with
CF3-Phg. The anisotropy of the homonuclear dipolar cou-
pling (including its sign) within the CF3 group is readily
analyzed in a simple one-pulse experiment (10,11). The CF3-
Phg side chain consists of an aromatic ring that is directly
connected to the Ca atom, with the CF3 group at the para
position. The CF3 group is rigidly attached to the peptide
backbone along the direction of the Ca-Cb bond. Orienta-
tional constraints from the CF3 group thus reﬂect the
behavior of the peptide backbone in an analogous manner
as the CD3 groups analyzed above. In the previous
19F-NMR
study of PGLa, we had selectively labeled positions Ile-9,
Ala-10, Ile-13, and Ala-14, which have now been labeled
with Ala-d3 for
2H-NMR.
From geometrical considerations, the CF3 group in CF3-
Phg should be oriented with respect to the peptide backbone
in the same way as the CD3 group in Ala-d3. Both the dipolar
and quadrupolar spin interactions experience an angular
dependence of ½(3cos2u  1), where u is the angle between
the Ca-Cb bond vector and the magnetic ﬁeld direction.
When considering either label in the same position of the
peptide sequence, the quadrupole splitting from the CD3
group and the dipolar coupling from the CF3 group should be
related to one another by a constant factor of 5.3. This factor
is the ratio between the maximum dipolar coupling
D0CF3 ¼ 15:8 kHz of a rotationally averaged CF3 group (10)
and the maximum quadrupole splitting D0CD3 ¼ 82 kHz of a
rotating CD3 group (4,40,41). Provided that the peptide
remains undistorted and has the same orientation in the
bilayer in both labeled analogs, then the two types of
splitting from any one position should be scaled by the same
constant factor, with ;5.3 times larger splittings in 2H. We
can thus compare the 19F dipolar couplings reported
previously (10,11) with the present 2H quadrupole splittings
in Table 3. In the current case, where the order parameters of
the two data sets are slightly different, this factor will scale
accordingly. For P/L ¼ 1:200, the order parameter found for
19F is 0.63, and for 2H it is 0.67, thus giving a factor of 5.6.
For P/L ¼ 1:50, the order parameters are 0.63 and 0.78,
respectively, giving a factor of 6.6.
At low peptide concentration, the ratios between the
dipolar and quadrupole splittings at positions Ile-13 and Ala-
14 are indeed close to the theoretical value. The small 19F
dipolar couplings at positions Ile-9 and Ala-10 were not well
resolved and had thus been set to 0 kHz. From the 2H-NMR
data, we can now conclude that dipolar couplings of 1.0 and
2.8 kHz, respectively, would have been expected for these
two CF3-Phg substituents. It is indeed plausible that the CF3
splitting at position Ile-9 is ;1 kHz, which is indeed too
small to be resolved in the dipolar triplet (data not shown, see
Glaser et al. (10)). Only the CF3-Phg label at position Ala-10
is not entirely consistent with the expected value. Neverthe-
less, when the signs of the quadrupole splittings are back-
calculated from the best-ﬁt values of the peptide tilt and
rotation angles, the predicted signs for position Ile-13 and
Ala-14 are the same as those that were directly observed by
19F-NMR. These good correlations indicate that it is possible
to use the sign of the NMR interaction (i.e., the CSA)
observed in 19F-NMR to reﬁne the quadrupolar 2H-NMR
analysis for which the sign is inaccessible otherwise. Given
the good correlation between the 2H- and 19F-NMR data at
low peptide concentration (P/L ¼ 1:200), it is not surprising
that the calculated structures of PGLa are similar when based
on either the 2H or 19F data in the analysis. Using four 19F
labels, the best ﬁt in our earlier work had given t  89, r 
TABLE 3 Comparison of CD3 quadrupole splittings and
CF3 dipolar couplings in PGLa (see text)
P/L Labeled position CD3 (kHz)* CF3 (kHz) CD3/CF3*
1:200 Ile-9 5.2y 0z n.a.
Ala-10 15.0y 0z n.a.
Ile-13 26.4y 15.6 4.8
Ala-14 26.6y 5.4 4.9
1:50 Ile-9 30.0 4.7 6.4
Ala-10 30.3 3.1 9.7
Ile-13 20.1 3.3 6.1
Ala-14 21.5 5.3 3.9
*Absolute values, no sign available.
yNonoriented samples, Pake splittings multiplied by 2.
zToo small to be experimentally resolved.
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106, and S  0.6 (10), for which the corresponding dipolar
wave is included here as a dotted line in Fig. 5 A.
At a high peptide concentration of P/L¼ 1:50, the picture is
somewhat different. Table 3 shows that the ratio of the dipolar
and quadrupole splittings deviates signiﬁcantly from the
expected factor (6.6 when taking the order parameter into
account) at the two positions of Ala-10 and Ala-14. This is
also seen in the wave plots of Fig. 5 B, where the 19F data
points of Ile-9 and Ile-13 are fully compatible with the
unperturbed PGLa structure (solid line), whereas the CF3-Phg
substitutions at Ala-10 and Ala-14 deviate notably. We may
suggest two possible explanations for this observation. It
would appear reasonable that a bulky Ile side chain can be
safely substituted by a similarly large CF3-Phg, whereas a
small Ala site cannot readily accommodate such bulky
substituent (although this argument cannot be generalized to
include all data at low peptide concentration). Alternatively, it
may not be the type of amino acid that is susceptible to
mutations but rather the mutated position on the helical wheel,
which may be involved in the putative dimer interface at high
peptide concentration. The helical wheel of Fig. 1 shows that
Ala-10 and Ala-14 are adjacent to one another in the three-
dimensional structure. Indeed, Ala-10 and Ala-14 have been
demonstrated by REDOR distance measurements to form the
dimer interface of the analogous peptide K3, whose sequence
(KIAGKIA)3 is derived from PGLa (23). Even though it is
purely speculative to draw such analogy, the current 2H- and
19F-NMR data are consistent with the possibility that also
PGLa may dimerize via its Ala-rich surface.
It is obviously not advisable to use any amino acid
substitutions for an NMR analysis when a structure needs to
be i), exactly known, or when ii), the peptide is expected to
oligomerize. Nevertheless, the comparison of our 2H- and
19F-NMR data shows that a rough picture of the peptide
conformation and alignment is still accessible and the overall
features are reliable, even when using nonnatural CF3-Phg
labels. That is, the values of t, r, and Smol calculated from the
four CF3-Phg substitutions are close to the results obtained
by the four nonperturbing 2H-NMR labels (Table 2). Hence
the conclusions of our previous 19F-NMR studies are still
fully valid, namely that PGLa undergoes a concentration-
dependent realignment in the membrane by ;30, taking it
from the surface-bound S-state to a novel tilted T-state. It has
to be noted that the peptide analogs with a CF3-Phg label at
position 9, 10, 13, or 14 still exhibit an antimicrobial activity
comparable to that of the wild-type PGLa (8). Only one label
at position Ala-8 on the hydrophilic face exhibited a reduced
activity and had thus been excluded from the earlier structure
analysis (10).
19F-NMR labeling strategy for peptides
The main advantage of using 19F-labeled peptides is the
exquisitely high sensitivity of 19F-NMR and the lack of a
natural abundance background. The results of our 2H-NMR
study demonstrate that for monomeric PGLa, the previously
used 19F-labels do not disturb the peptide-lipid system. CF3-
Phg is therefore a very useful label, which also provides the
sign of the dipolar coupling via the CSA interaction, which is
not available for the quadrupole splitting. Given the high
sensitivity of 19F-NMR, small amounts of peptide and short
NMR acquisition times produce strong signals. It is therefore
advantageous to use 19F-labeled peptides for systematically
monitoring a wide range of sample conditions, e.g., lipid
composition, temperature, pH, and peptide concentration.
For PGLa in DMPC, molar peptide/lipid ratios as low as
1:3000 have been examined that way. With increasing
peptide concentration up to 1:8, a sigmoidal curve of NMR
parameters was obtained suggesting a realignment at;1:100
(9,11). When such 19F-NMR studies indicate that under
certain conditions some interesting structural changes occur,
then some nonperturbing, but less sensitive labels like 15N
and 2H, can be introduced to obtain a more accurate picture
of the peptide under those selected conditions. Having ac-
quired the two sets of 19F- and 2H-NMR data with the same
FIGURE 5 Dipolar wave plots of our current 2H-NMR data at P/L ¼
1:200 (A) and P/L¼1:50 (B), for comparison with our previous 19F-NMR
data on PGLa acquired with CF3-Phg labels. The solid curves represent the
unperturbed peptide structure as calculated from the best-ﬁt 2H-NMR
parameters of native Ala substitutions, whereas the dotted curves are
calculated from the best ﬁt to the CF3 data (solid squares, cf. Table 3).
Deviations of any CF3-Phg substituents from the ideal peptide structure are
indicated.
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peptide, a direct comparison of their relative sensitivities
shows that 0.25 mg of CF3-Phg labeled PGLa gave a good
signal in 2 h, whereas 2 mg of CD3-labeled peptide gave an
acceptable signal after 5 h. In practical terms, the theoret-
ically expected 100-fold gain in sensitivity of 19F-NMR over
2H-NMR is thus reduced to an effective factor of 20, due to
the favorable quadrupolar relaxation of deuterium allowing
fast recycle delays (51).
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